SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Zim $4.5 billion bidder faces foreclosure on his home

NextVision insiders cash out $200 million in share sale

"If an engineer in Ireland costs 20% less, it is clearly part of the consideration when deciding where to expand"

Electra Real Estate CEO: “The $7 trillion US rental housing market is the place to be”

Buzz

Most popular

Daily

Weekly

1

Jewish family from Mexico donates NIS 200 million to establish Israel's largest rehabilitation hospital

2

After raising $20 million, collapsed startup Swish.ai sells to Unframe for just $150,000

3

Echo: “Employees have become very good at identifying performative culture”

4

After PTSD and years of insomnia, Israeli founder raises $6.5 million to improve sleep through scent

5

Israeli unicorn AppsFlyer in advanced talks for $1-2 billion sale

Medtech

20 stories about Medtech

Salignostics founders

Salignostics receives $1.87 million Gates Foundation grant for saliva-based HIV and pregnancy tests

Funding to accelerate non-invasive diagnostics aimed at improving access in developing regions.

מנכ"ל ביופרוטקט איתי ברנע ו משרדי אולימפוס ב הולנד

Olympus to buy Israel’s BioProtect for $270 million in cash

26.05.26|Meir Orbach

Japanese medtech group expands into prostate cancer treatment devices with all-cash deal.

קווין מייברי מנכ"ל אנדוספאן Endospan

Artivion to acquire Israeli medtech firm Endospan in deal worth up to $335 million

18.05.26|Meir Orbach

FDA approval for Endospan’s aortic repair system triggers long-awaited acquisition option.

אבנר הלפרין מנכ״ל שיבא אימפקט

“We're too slow in the adoption of AI technologies in healthcare”

05.05.26|Zachy Hennessey

Sheba Impact CEO Avner Halperin explains why AI is becoming central to telehealth, from triage and intake to expanding access to care while keeping clinicians in the loop.

מטה מדטרוניק באונטריו קנדה

Medtronic to lay off 60 employees at Jerusalem R&D center

27.10.25|Maayan Cohen Rozen

U.S. medical device giant moves to streamline operations as part of a global realignment.

ארליך ניו פייז - כדור ברזל נגד סרטן

The startup that wants to redefine stage four cancer

23.10.25|Hagai Gilboa, Maor Shalom Swisa

By heating tumors at the cellular level, New Phase hopes to transform treatment outcomes.

מייסדי איידוק Aidoc מימין גיא ריינר אלעד וולך מיכאל ברגינסקי

Aidoc receives Breakthrough Device Designation from FDA for multi-triage imaging AI

“The new technology means our mission is at hand - to support physicians in every patient encounter,” said Elad Walach, Co-Founder and CEO.

Edit Goldberg CEO Escala Medical

Escala Medical raises $4.5M Series A for safer pelvic prolapse treatment

21.07.25|Amy Shapiro

Co-financed by the EIC Fund, the raise will support global expansion of Escala’s FDA-approved women’s health solution for pelvic organ prolapse.

Restore Medical team

Restore Medical secures $23M Series B to push forward novel heart failure therapy

The new funding will allow the Israeli startup to complete an ongoing feasibility study in Europe, where early results have shown what the company describes as encouraging long-term safety and efficacy data.

מייסדי פורסייט רובוטיקס מימין פרופ' משה שהם ד"ר יוסי נתן דניאל גלוזמן

ForSight Robotics raises $125M Series B to advance AI-powered eye surgery system

24.06.25|Meir Orbach

Israeli medtech firm’s ORYOM platform aims to expand access to precision eye care globally.

Yehuda Tal NimBio

NimBio unveils AI-powered Inflammometer to predict IBD flares before they strike

The company has raised a total of $2 million for its non-invasive technology, helping those with Inflammatory Bowel Diseases.

Canopy appoints Avi Revivo as CTO and GM Israel

“His joining will help us realize the full potential of AI in oncology, significantly increase the value we provide to our clients, and create real impact in patients’ lives,” said Founder and CEO Lavi Kwiatkowsky.

Micha Somite Team

Somite AI secures $47.5 million Series A to expand AI platform for cell therapy

13.05.25|James Spiro

The company is developing DeltaStem, an AI-driven platform designed to improve the production of human cells for therapeutic use.

אבנר הלפרין מנכ״ל שיבא אימפקט ומרכז החדשנות ARC

How combat medicine accelerates innovation and reshapes global healthcare

29.04.25|Avner Halperin

"We must ensure that the medical inventions arising from today’s combat realities evolve into tangible healthcare products that save lives - not only on the battlefield but also on highways, in trauma centers, and operating rooms worldwide," writes Avner Halperin, CEO of Sheba Impact and the ARC Innovation Center at Sheba Medical Center.

איל ליפשיץ שותף מנהל בקרן פרגרין ונצ'רס

The secret to the success of Israel’s medical device industry

09.04.25|Eyal Lifschitz

"Global medical device companies are actively scouting Israeli startups—many of which are founded by alumni of those same corporations—as they search for future growth engines," writes Eyal Lifschitz, Managing Partner at Peregrine Ventures.

Sheba Medical Center unveils three new AI centers for hospital care

06.03.25|James Spiro

The AI Center, ‘Project K’, and an AI Academy each mark a significant shift in the integration of AI into modern medicine.

ForSight Robotics appoints surgical robotics pioneer Dr. Fred Moll to its board

ForSight has also added Yonatan Ushpizin as vice president of research and development and Ilanit Edri as vice president of people.

BD חברה בתחום המכשור הרפואי סניף קליפורניה

BD to close Israeli manufacturing plant and lay off 200 employees

27.01.25|Meir Orbach

The global medical device company moving operations abroad as part of a strategy to streamline its supply chain.

מייסדי אנדוסטרים מדיקל מימין אלון מאי סמנכ"ל הטכנולוגיות ו דנאל מאייר המנכ"ל

Japanese giant Kaneka acquires EndoStream Medical in $100 million deal

09.01.25|Meir Orbach

Israeli-developed implant eliminates the need for blood thinners in aneurysm treatment.

תום ליבנה מייסד ויו"ר ורביט

Former Verbit CEO Tom Livne launches new startup, leveraging AI to tackle drug development challenges

08.01.25|Meir Orbach

Grace, which aims to repurpose abandoned drugs through advanced artificial intelligence, is expected to raise its first funding round in the coming weeks, targeting $10–20 million.